Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...

A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with ...

A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...

Scarlet Therapeutics ("Scarlet") today announces a landmark preclinical result: its proprietary cell-line derived, universal, lab-grown red blood cells (“RBCs”) have successfully matured and ...

A University of Bristol spin-out which has developed a platform for generating therapeutic red blood cells (tRBCs) to treat ...

About 100,000 Americans have sickle cell disease (SCD), the most common inherited blood disorder in the US. Roughly 10% of ...

A University of Bristol spin-out developing a platform that generates therapeutic red blood cells to treat a range of ...

World Thalassemia Day: In India, beta-thalassemia is the more prevalent type and continues to be a major public health issue.

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...

Huntsville Hospital is expanding care options for patients with blood disorders, launching a new outpatient red blood cell ...

TERRIBLE. NEBRASKA ADVOCATES URGE PEOPLE TO ROLL UP THEIR SLEEVES TO SUPPORT SICKLE CELL AWARENESS MONTH. THE RED BLOOD CELL DISORDER AFFECTS 8 MILLION PEOPLE WORLDWIDE. PATIENTS REQUIRE REGULAR BLOOD ...